The two studies published Monday are a potential game-changer for companies pursuing CRISPR-based therapies, but as one researcher said, "I don't think it's a deal-breaker." | Continue reading
Suennen has a reputation as an irreverent straight-talker and, as the lead health care investor for GE's corporate venture arm, she has a knack for deflating doomed business models and bad ideas. | Continue reading
One of the nation's most popular online genealogy sites said the email addresses and hashed passwords of 92 million users had been found on an outside server, raising concerns about the security of more sensitive data that the company collects. | Continue reading
The agency has suspended enrollment in the study following concerns over the alcoholic beverage industry’s role in funding it. | Continue reading
A day after social media tore into geneticist Eric Lander for toasting James Watson, the co-discoverer of the double helix who in his later years has become known for racist and misogynist views, on his 90th birthday, the director of the Broad Institute of MIT and Harvard issued … | Continue reading
Many scientists greeted the finding with skepticism, because the work needs to replicated, and the results fly in the face of a massive amount of evidence supporting the deeply entrenched idea that memories are stored through changes in the strength of connections, or synapses, b … | Continue reading
“If the Broad wins in the U.S. and UC has the upper hand in Europe, they may decide it’s worth splitting the difference,” said one patent expert. | Continue reading